Drug
Aav Gad
Aav Gad: highest development phase Phase 1/2, developed by MeiraGTx. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- MeiraGTx
Trials
| Drug | Phase | Indication |
|---|---|---|
| AAV-GAD NCT05894343 | Phase 1/2 | Parkinson's Disease |
Latest
No recent events.
Follow Aav Gad on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.